Manufacturing Cell Therapies: Development Strategies for Commercial Vision

In this informative eight-page white paper by Brian Hampson, VP of Manufacturing Development & Engineering at PCT, and Richard Grant, Global VP of Cell Therapy at Invetech, you’ll learn how to:

  • Define a Quality Target Product Profile for your cell therapy product early in development

  • Discover manufacturing equipment and strategies that maximize quality, scalability, and sustainability

  • Improve cost-effectiveness and commercial viability

  • Reduce the need for a large up-front investment by integrating and automating patient-specific cell therapy processes

  • Understand the importance of communication and the characteristics of a successful relationship between a cell therapy developer and a contract development and manufacturing organization (CDMO)

Optia_group_9335circle.png